UW spinout Neoleukin Therapeutics goes public in acquisition

//UW spinout Neoleukin Therapeutics goes public in acquisition

UW spinout Neoleukin Therapeutics goes public in acquisition

The public company will change its name to Neoleukin Therapeutics and will be based in Seattle when the deal closes.

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2019-08-08T06:02:57+00:00 August 8th, 2019|Healthcare|

About the Author: